Sae-sim, N.; Samarnthai, N.; Numprasit, W.
Reply to Venkataraman, J.; Mokbel, K. Reconsidering the Interpretation of “Recurrence-Free Survival” After Mastectomy for DCIS. Comment on “Sae-sim et al. Tamoxifen Reduces Breast Cancer Recurrence in Women with DCIS Who Underwent Mastectomy. Curr. Oncol. 2026, 33, 89”. Curr. Oncol. 2026, 33, 248.
https://doi.org/10.3390/curroncol33050248
AMA Style
Sae-sim N, Samarnthai N, Numprasit W.
Reply to Venkataraman, J.; Mokbel, K. Reconsidering the Interpretation of “Recurrence-Free Survival” After Mastectomy for DCIS. Comment on “Sae-sim et al. Tamoxifen Reduces Breast Cancer Recurrence in Women with DCIS Who Underwent Mastectomy. Curr. Oncol. 2026, 33, 89”. Current Oncology. 2026; 33(5):248.
https://doi.org/10.3390/curroncol33050248
Chicago/Turabian Style
Sae-sim, Netchanok, Norasate Samarnthai, and Warapan Numprasit.
2026. "Reply to Venkataraman, J.; Mokbel, K. Reconsidering the Interpretation of “Recurrence-Free Survival” After Mastectomy for DCIS. Comment on “Sae-sim et al. Tamoxifen Reduces Breast Cancer Recurrence in Women with DCIS Who Underwent Mastectomy. Curr. Oncol. 2026, 33, 89”" Current Oncology 33, no. 5: 248.
https://doi.org/10.3390/curroncol33050248
APA Style
Sae-sim, N., Samarnthai, N., & Numprasit, W.
(2026). Reply to Venkataraman, J.; Mokbel, K. Reconsidering the Interpretation of “Recurrence-Free Survival” After Mastectomy for DCIS. Comment on “Sae-sim et al. Tamoxifen Reduces Breast Cancer Recurrence in Women with DCIS Who Underwent Mastectomy. Curr. Oncol. 2026, 33, 89”. Current Oncology, 33(5), 248.
https://doi.org/10.3390/curroncol33050248